Your cart is empty.
From small molecules in DMSO to biomolecules in surfactant-containing aqueous solutions, this convenient benchtop solution allows rapid delivery of picoliter to microliter volumes of your compound into your assay plate
Requiring almost no set-up time, it uses disposable Dispenseheads to minimize dead volumes and virtually eliminate the risk of cross-contamination, offering high quality, low volume dispensing for a wide range of applications.
Listen to Dr. David Donner, Professor at UCSF, to learn how his cancer research is facilitated by using the D300e Digital Dispenser.
Do you want to see how digital dispensing works in practice? Schedule an online software demo!
Serial dilutions can be a thing of the past! Dispense directly from your stock solution to any plate format (12-1536 well plates). Take advantage of our dedicated software wizards for dose-response, synergy, PCR or enzyme profile experiements.
Finally - normalize and randomize the layout to improve reliability of collected data. Find out how Tecan D300e can save your day in the lab!
The Tecan D300e Digital Dispenser offers a simple method for generating dose-response curves, synergy experiments, enzyme profiles and setting up PCR reactions.
Using HP’s Direct Digital Dispensing technology, it provides picoliter to microliter non-contact dispensing of liquids directly into the assay plate, saving time, minimizing consumption of valuable samples and accelerating research.
Create any plate map and dispense any dose in any well. Even randomize the plate with only one click! The Tecan D300e's software is so simple to use that one can create any plate map desired in only minutes!
Use your time more efficiently in follow up studies. D300eControl software makes it easy to generate dilution series, leading to more precise determination of Hill slopes and IC50 values.
Minimizes manual pipetting, enabling scientists to focus on more important tasks and reducing repetitive strain injuries. Enhances throughput with simple, yet sophisticated, software and application-focused wizards. Automatically calculates all concentrations and volumes for faster, simpler plate set-up.
Dispense your reagents directly into your assay plate and onto your cells.
In vitro drug combination studies are becoming more and more. The Tecan D300e, due to independent dosing of each compound and a software wizard, finally makes it possible to execute these experiments with ease.Learn more
The Tecan D300e’s Enzyme Profile wizard makes it quick and easy to set up titrations using differing combinations of enzymes or substrates in aqueous buffers, and inhibitors or other small molecules in DMSO.Learn more
The Tecan D300e’s PCR wizard makes it quick and easy to set up (q)PCR reactions in just 4 guided steps. Miniaturize your reaction volume and save on reagents and precious samples.Learn more
The Tecan D300e makes long, laborious workflows possible to standardize. This technology removes the need for many wasteful steps, getting to results faster.
The Tecan D300e is a cost-effective solution designed to accelerate drug discovery workflows by:
The system’s powerful software combines advanced experimental design with intuitive operation, allowing you to set up a wide range of experiments – including synergistic studies and randomized plate layouts – in minutes, saving you time without compromising on quality.
Expert training by Tecan ensures instant operation of the digital dispenser.
Repetitive manual pipetting and tedious serial dilutions for drug discovery assays just became a thing of the past.With Tecan’s D300e Digital Dispenser, you can automatically dispense any volume into any well of any assay plate, quickly and easily. Simply add your liquid to the Dispensehead and let the instrument do the rest.
DISPENSING FEATURES / FLUID REQUIREMENTS / FLUID CLASSES / DIMENSIONS
T8+ Dispensehead Cassette
D4+ Dispensehead Cassette
Personalized treatments have the greatest potential to benefit cancer patients. Guided selection of the most suitable drug or combination of drugs for a specific patient’s cancer profile and genetics avoids a trial-and-error treatment strategy and minimizes collateral effects. In this eBook we have compiled examples of how Tecan’s benchtop solutions can support these workflows.
The data presented in this application note demonstrates that the D300e can be used to miniaturize qPCR reactions to volumes as low as 2 μl and in addition offers greater process security and speed of the automated set-up.
The application note shows that the D300e is a suitable tool for qPCR set-up, offers significant sample, primer and reagent savings, and greatly reduces workflow time.
The data presented in this application note underlines the suitability of the D300e for protein-based assays.
The results generated with the D300 are consistent with an expertly performed manual process, but with the benefit of significant time savings and the elimination of serial dilution.
This technical note demonstrates, how easy it is to generate even the most complex plate layouts, like enzyme profiles, with the D300.
Brain tumors are the most common cause of mortality in childhood cancer patients, and treatment options are limited, especially for recurrent cases. Researchers at the University Hospital Düsseldorf are using automation to develop a more personalized approach to cancer medicine, performing rapid drug screening to identify novel therapeutic strategies to improve the chances of survival.
California-based company zPREDICTA™ has created a novel technology that reconstructs physiologically-relevant organ-specific human microenvironments that help eliminate the guesswork from drug development. Meaningful drug discovery studies involve complex experiments that are not feasible to perform manually. Automation is the answer, improving accuracy, saving time and reducing the amount of compound used.
Developing cancer drugs for clinical trials involves not only identifying and evaluating suitable agents, but also observing how they interact with the cocktail of other drugs in a cancer treatment regime. For the Telethon Kids Cancer Centre in Perth, Western Australia, increasing throughput and reducing assay volumes are essential to save money and time in the race to beat cancer.
The direct digital dispensing capabilities of the HP D300 are helping to identify potential new treatments for acute lymphoblastic leukemia at University Children’s Hospital Zurich. By enabling picoliter drug volumes to be dispensed straight into cell-based assay plates, the system is helping researchers to rapidly test novel drug combinations directly in patient-derived leukemia cells.
The HP D300 Digital Dispenser has enabled Translational Drug Development in the USA to automate its workflows, increasing sample throughput and the number of cell line panels handled, as well as enhancing workflow efficiency.
AstraZeneca scientists engaged in surface plasmon resonance studies are reaping the benefits of a recently acquired HP D300 Digital Dispenser, saving time, enhancing consistency and using significantly less compound for dose-response experiments.
Tecan has worked with promega to demonstrate the suitability of the Infinite® 200 PRO and HP D300 Digital Dispenser for real-time kinetic investigation of cytotoxicity using Promega’s CellTox™ Green Dye.
GlaxoSmithKline’s quest for improved anti-malarial treatments has been revolutionized by the speed and reliability of the HP D300 Digital Dispenser. This innovative system has increased throughput for standard drug titrations and enabled combinations of candidate compounds to be tested much more easily.
Symrise is using an HP D300 Digital Dispenser to improve throughput and reproducibility in its cell and molecular biology laboratories, offering more reproducible results for cosmetic active ingredient testing.
The Stanford genome Technology Center has invested in an HP D300 Digital Dispenser to study the effects of small molecule chemical inhibitors in yeast, enabling more experiments to be carried out more easily, and in less time.
TES Pharma is a specialist biotechnology company which performs molecular, cellular and ADME screening for drug discovery. The Company has recently purchased an HP D300 Digital Dispenser, and is now reaping the benefits of direct titration with improved assay reproducibility and more time to perform exploratory research.
In the last issue of the Tecan Journal, we announced the availability of the revolutionary HP D300 Digital Dispenser exclusively through Tecan’s Life Science Business. As customers in Europe and North America begin to place their orders, Kevin Peters, HP Global Sales Development Manager, reports on early customer experiences with the new technology.
For high volume non contact dispensing from 1nL to 10µL 20 cassettes/sales unit
For non contact dispensing from 11pL to 10µL 20 cassettes/sales unit